PDE7B is a novel, prognostically significant mediator of glioblastoma growth whose expression is regulated by endothelial cells

Authors

Michael D. Brooks, Washington University School of Medicine in St. Louis
Erin Jackson, Washington University School of Medicine in St. Louis
Nicole M. Warrington, Washington University School of Medicine in St. Louis
Jingqin Luo, Washington University School of Medicine in St. Louis
Jason T. Forys, Washington University School of Medicine in St. Louis
Sara Taylor, Washington University School of Medicine in St. Louis
Diane D. Mao, Washington University School of Medicine in St. Louis
Jeffrey R. Leonard, Washington University School of Medicine in St. LouisFollow
Albert H. Kim, Washington University School of Medicine in St. LouisFollow
David Piwnica-Worms, Washington University School of Medicine in St. Louis
Robi D. Mitra, Washington University School of Medicine in St. Louis
Joshua B. Rubin, Washington University School of Medicine in St. Louis

Journal

PLoS One

Publication Date

2014

Volume

9

Issue

9

Inclusive Pages

e107397

Document Type

Open Access Publication

DOI

10.1371/journal.pone.0107397

Rights and Permissions

Brooks MD, Jackson E, Warrington NM, Luo J, Forys JT, et al. (2014) PDE7B is a novel, prognostically significant mediator of glioblastoma growth whose expression is regulated by endothelial cells. PLoS ONE 9(9): e107397. doi: 10.1371/journal.pone.0107397

Recommended Citation

Brooks, Michael D.; Jackson, Erin; Warrington, Nicole M.; Luo, Jingqin; Forys, Jason T.; Taylor, Sara; Mao, Diane D.; Leonard, Jeffrey R.; Kim, Albert H.; Piwnica-Worms, David; Mitra, Robi D.; and Rubin, Joshua B., "PDE7B is a novel, prognostically significant mediator of glioblastoma growth whose expression is regulated by endothelial cells." PLoS One. 9, 9. e107397. (2014).
https://digitalcommons.wustl.edu/open_access_pubs/3409